Literature DB >> 29799737

Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release.

Daiqin Chen1,2,3, Guoqiang Zhang1,2, Ruimin Li1,2, Mirong Guan1,2, Xueyun Wang1,2, Toujun Zou1,2, Ying Zhang1,2, Chunru Wang1, Chunying Shu1, Hao Hong3, Li-Jun Wan1,2.   

Abstract

Reactive oxygen species (ROS) and glutathione (GSH) dual responsive nanoparticulate drug delivery systems (nano-DDSs) hold great promise to improve the therapeutic efficacy and alleviate the side effects of chemo drugs in cancer theranosis. Herein, hydrogen peroxide (H2O2) and GSH dual responsive thioketal nanoparticle (TKN) was rationally designed for paclitaxel (PTX) delivery. Compared to other stimuli-sensitive nano-DDSs, this dual responsive DDS is not only sensitive to biologically relevant H2O2 and GSH for on-demand drug release but also biodegradable into biocompatible byproducts after fulfilling its delivering task. Considering the heterogeneous redox potential gradient, the PTX loaded TKNs (PTX-TKNs) might first respond to the extracellular ROS and then to the intracellular GSH, achieving a programmable release of PTX at the tumor site. The selective toxicity of PTX-TKNs to tumor cells with high levels of ROS and GSH was verified both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29799737     DOI: 10.1021/jacs.7b12025

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  24 in total

1.  Self-Amplified Photodynamic Therapy through the 1 O2 -Mediated Internalization of Photosensitizers from a Ppa-Bearing Block Copolymer.

Authors:  Zhiyong Liu; Tianye Cao; Yudong Xue; Mengting Li; Mengsi Wu; Jonathan W Engle; Qianjun He; Weibo Cai; Minbo Lan; Weian Zhang
Journal:  Angew Chem Int Ed Engl       Date:  2020-01-30       Impact factor: 15.336

Review 2.  Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases.

Authors:  William C Ballance; Ellen C Qin; Hee Jung Chung; Martha U Gillette; Hyunjoon Kong
Journal:  Biomaterials       Date:  2019-06-21       Impact factor: 12.479

Review 3.  Supramolecular nanomedicines through rational design of self-assembling prodrugs.

Authors:  Han Wang; Maya Monroe; Faith Leslie; Charles Flexner; Honggang Cui
Journal:  Trends Pharmacol Sci       Date:  2022-04-19       Impact factor: 17.638

4.  Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.

Authors:  Sa-Hoe Lim; Chun-Hao Li; Young-Il Jeong; Woo-Youl Jang; Jin-Myung Choi; Shin Jung
Journal:  Int J Nanomedicine       Date:  2019-11-13

Review 5.  Recent Advances in Stimuli-Sensitive Amphiphilic Polymer-Paclitaxel Prodrugs.

Authors:  Man Zhou; Lijuan Wen; Cui Wang; Qiao Lei; Yongxiu Li; Xiaoqing Yi
Journal:  Front Bioeng Biotechnol       Date:  2022-04-06

6.  Ameliorative effect of gallic acid in paclitaxel-induced neuropathic pain in mice.

Authors:  Satbir Kaur; Arunachalam Muthuraman
Journal:  Toxicol Rep       Date:  2019-06-07

7.  Self-accelerating H2O2-responsive Plasmonic Nanovesicles for Synergistic Chemo/starving therapy of Tumors.

Authors:  Yao Tang; Yuejia Ji; Chenglin Yi; Di Cheng; Bin Wang; Yun Fu; Yufang Xu; Xuhong Qian; Yahya E Choonara; Viness Pillay; Weiping Zhu; Yunen Liu; Zhihong Nie
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

Review 8.  Cerium Oxide Nanoparticles: A Brief Review of Their Synthesis Methods and Biomedical Applications.

Authors:  Atul Dhall; William Self
Journal:  Antioxidants (Basel)       Date:  2018-07-24

9.  Near-infrared light and tumor microenvironment dual responsive size-switchable nanocapsules for multimodal tumor theranostics.

Authors:  Zhiyi Wang; Yanmin Ju; Zeeshan Ali; Hui Yin; Fugeng Sheng; Jian Lin; Baodui Wang; Yanglong Hou
Journal:  Nat Commun       Date:  2019-09-27       Impact factor: 14.919

10.  In situ tumor-triggered subcellular precise delivery of multi-drugs for enhanced chemo-photothermal-starvation combination antitumor therapy.

Authors:  Xinglu Jiang; Xiaobo Fan; Rui Zhang; Wei Xu; Hailu Wu; Fengfeng Zhao; Han Xiao; Chen Zhang; Chenggui Zhao; Guoqiu Wu
Journal:  Theranostics       Date:  2020-10-27       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.